Activity-regulated cytoskeleton-associated protein (Arc) is a brain-enriched immediate early gene that regulates important mechanisms implicated in learning and memory. Arc levels are controlled through a balance of induction and degradation in an activity-dependent manner. Arc further undergoes multiple post-translational modifications that regulate its stability, localization and function. Recent studies demonstrate that these features of Arc can be pharmacologically manipulated. In this review, we discuss some of these compounds, with an emphasis on drugs of abuse and psychotropic drugs. We also discuss inflammatory states that regulate Arc.
Refinement of developing visual projections is reported to depend on visual experience in rats, cats, ferrets, and monkeys. Visual deprivation in these species delays visual pathway development, reportedly maintaining a juvenile condition and prolonging the critical period for plasticity. Deprivation has been associated with retention of immature NMDA and GABAA receptors and a juvenile state of chloride transporters. In contrast, receptive fields (RFs) in superior colliculus (SC) and visual cortex (V1) of Syrian hamsters refine normally with spontaneous activity alone, requiring visual experience only to maintain refined RFs in adulthood. Continued visual deprivation into adulthood leads to RF enlargement. This failure to maintain refined RFs and thus preserve high acuity vision in visually deprived adult SC is associated with a loss of GABA and GAD, caused at least in part by a reduction in BDNF-TrkB signaling. In order to explore the postsynaptic mechanism, we examined GABAA receptor expression levels, location, and subunit composition using Western blotting. In addition, we assayed the GABAA receptor anchoring protein gephyrin and expression levels of the chloride transporters KCC2 and NKCC2. To test the alternate hypothesis that RFs enlarge in adulthood as a result of immature postsynaptic NMDA receptors, we examined NR2A/2B ratios and levels of the anchoring protein PSD-95. We found no evidence supporting visual deprivation-related postsynaptic alterations in receptors, chloride transporters, or anchoring proteins in adult hamsters. Thus, we argue that visual deprivation continued past puberty reveals a new form of maladaptive, inhibitory plasticity in which, rather than retaining juvenile features and extending the critical period, continued lack of inhibition in adulthood reopens the critical period, reversing the refinement of receptive fields to the detriment of visual acuity. These results suggest that attempts to increase plasticity in adulthood for purposes of rehabilitation or recovery from injury should consider the possibility of unintended negative consequences.
Mitochondrial fission regulates mitochondrial morphology, function, mitophagy and apoptosis. Fission is mediated by the GTPase dynamin related protein-1 (DRP1) and its recruitment to the outer mitochondrial membrane by DRP1 receptors. Mitochondrial fission factor (MFF) is considered the major pro-fission receptor, whereas the mitochondrial dynamics proteins (MiD49/51) sequester inactive DRP1 and facilitate the MFF-DRP1 interaction by forming a trimeric DRP1-MiD-MFF complex. Here, we identify MFF as a target of poly-SUMOylation at a single residue (Lys151). Following bioenergetic stress, AMPK phosphorylates MFF to promote its SUMOylation, a critical step in stress-induced fragmentation. MFF SUMOylation is not required for DRP1 recruitment from the cytosol but causes a rearrangement of the trimeric fission complex to displace MiD proteins. This alleviates MiD inhibition of DRP1 to facilitate formation of a fission-competent complex. Thus, our data demonstrate that MFF SUMOylation fine-tunes the ratio of MiD to DRP1 for the dynamic control of stress-induced mitochondrial fragmentation.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.